XENIOS AG delivers highest quality products while adhering to the highest ethical standards and practices in the industry.

The XENIOS AG Code of Conduct provides useful guidance for the holding and the single companies or therapy brands (novalung, i-cor, medos). As required by both United States and French laws, U.S. Sunshine Act and Loi Bertrand, XENIOS AG publicly discloses its interactions with both U.S. and French health care professionals.